Apellis Pharmaceuticals to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Company Announcement - Apellis Pharmaceuticals, Inc. will present at the Goldman Sachs 46th Annual Global Healthcare Conference on June 11, 2025, at 10:40 a.m. ET [1] - A live conference webcast will be available on the company's website, with a replay accessible for approximately 90 days post-event [1] Company Overview - Apellis Pharmaceuticals is a global biopharmaceutical company focused on developing therapies for challenging diseases [2] - The company has introduced the first new class of complement medicine in 15 years, with two approved medicines targeting C3 [2] - Apellis has launched the first-ever therapy for geographic atrophy, a major cause of blindness globally, and aims to explore the potential of targeting C3 in various serious diseases [2]